In the News: 09/06

Kyphoplasty pain improvement questioned; Anakinra only marginally effective for long-term use; Celecoxib poses fewer gastrointestinal risks than NSAIDs; Protein boost builds new bone
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access